Snowball logo
logo
BMHS

Bundamedik Tbk PT

BMHS • JK
Rp199.00+Rp1.00  (0.51%)
Estimate
EPS
-0.2
Beta
-0.216
Growth
Revenue, YoY
4.67%
Net income, YoY
-1,634.28%
FCF, YoY
-3,295.29%
Forecast
P/E (FWD)
47.4
EPS (FWD)
4.2
Dividends
Dividend yield
0.52%
Annual payout
Rp1.03
Next ex. div date
June 23, 27
Payout
132.08%
Dividend growth streak
2 y
Div.rating
About the company
Ticker
BMHS
ISIN
ID1000161201
Country
Indonesia
Sector (GICS)
Healthcare
PT Bundamedik Tbk provides health care services in Indonesia. It also engages private hospital and healthcare support service activities; provision of ambulance services; private health education; consultant for reproductive technology services management; management consultant of physiotherapy service; and hotel, and dental clinic services management consulting businesses. It also provides fertility clinic, and oncology; emergency services; laboratory, radiology, and IVF services; and genomics and clinical pathology laboratory, and corporate health services. In addition, the company operates a BMHS nurse center, bunda neuro centre, bunda heart centre, bunda urology centre, digital substraction angiography, RSM oncology, and advanced robotic minimal invasive surgery. PT Bundamedik Tbk was founded in 1961 and is based in Jakarta Pusat, Indonesia. PT Bundamedik Tbk is a subsidiary of PT Bunda Investama Indonesia.

Frequently asked questions

What sector does Bundamedik Tbk PT (BMHS) operate in?

Bundamedik Tbk PT belongs to the Healthcare sector and operates in the Medical Care Facilities industry.

What is Bundamedik Tbk PT (BMHS) current stock price?

As of the latest data, Bundamedik Tbk PT stock price is IDR 199, with a previous close of IDR 198. Bundamedik Tbk PT gained IDR 1 in the last trading session, representing a 0.51% increase.

What is Bundamedik Tbk PT (BMHS) current market capitalization?

Bundamedik Tbk PT market cap is approximately 1.71 trillion.

What is Bundamedik Tbk PT (BMHS) Earnings Per Share (EPS)?

The trailing EPS is -IDR 0, and the forward EPS is IDR 4.

What is Bundamedik Tbk PT (BMHS) EBITDA?

Bundamedik Tbk PT EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 22.04 billion.

Does Bundamedik Tbk PT (BMHS) pay dividends?

Yes. Bundamedik Tbk PT pays annual dividends with an annualized yield of 0.52% and an estimated annual payout of IDR 1 per share.

When is the next ex-dividend date for Bundamedik Tbk PT (BMHS)?

The next ex-dividend date is scheduled for June 23, 2027.

What is Bundamedik Tbk PT (BMHS) beta (volatility) score?

Bundamedik Tbk PT has a beta of -0.216, indicating lower volatility than the overall market.